Annals of Tropical Medicine and Public Health
Home About us Ahead Of Print Instructions Submission Subscribe Advertise Contact e-Alerts Editorial Board Login 
Users Online:257
  Print this page  Email this page Small font sizeDefault font sizeIncrease font size
 


 
Table of Contents   
EDITORIAL COMMENTARY  
Year : 2012  |  Volume : 5  |  Issue : 3  |  Page : 149
Cancer risk assessment and cancer prevention: Promises and challenges


World Hope Foundation, Suite 2, 4041 Road Office Complex, Festac Town, Nigeria

Click here for correspondence address and email

Date of Web Publication17-Jul-2012
 

How to cite this article:
Olugbemi O. Cancer risk assessment and cancer prevention: Promises and challenges. Ann Trop Med Public Health 2012;5:149

How to cite this URL:
Olugbemi O. Cancer risk assessment and cancer prevention: Promises and challenges. Ann Trop Med Public Health [serial online] 2012 [cited 2018 May 22];5:149. Available from: http://www.atmph.org/text.asp?2012/5/3/149/98601
Despite intense efforts to cure cancers through advances in staging, surgery, chemo- and radiation therapy, treatment of most advanced, symptomatic epithelial malignancies continues to be challenging, and age-adjusted cancer mortality in the United States has decreased by only 5% since 1950. The clinical course of treated cancer patients all too often culminates in relapse and death. Ironically, growing evidence also suggests that many patients with pre-malignancy or even malignancy follow benign courses and die far more often of non-cancer causes than of cancer. These paradoxical phenomena form the dilemma of early detection-under detection of life-threatening early disease and over detection of indolent early disease. Personalized medicine promises dramatic reductions in cancer mortality by identifying the patients at risk of cancer mortality and treating them before deep invasion, metastasis and death. The challenge for personalized medicine is to improve cancer risk assessment so that cancer prevention and early detection can focus on high-risk patients in whom interventions have the greatest probability of prolonging productive life expectancy.

Top
Correspondence Address:
Oludotun Olugbemi
World Hope Foundation, Suite 2, 4041 Road Office Complex, Festac Town
Nigeria
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1755-6783.98601

Rights and Permissions




 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Email Alert *
    Add to My List *



 Article Access Statistics
    Viewed1258    
    Printed94    
    Emailed0    
    PDF Downloaded9    
    Comments [Add]    

Recommend this journal